Findings on Immune Response Inform Direction of HIV Vaccine Development
Fred Hutchinson Cancer CenterAnalyses of landmark RV144 HIV vaccine study volunteers revealed that those who developed a unique set of vaccine-induced antibodies in combination with a high level of CD4 T-cell responses to the outer portion of the HIV virus, called its envelope gene, correlated with reduced HIV infection.